Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction

QR Code

Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction

A multi-marker approach for assessing the prognosis of patients with ST-segment elevation myocardial infarction (STEMI) is a promising strategy.Aim. To assess the potential prognostic power of soluble growth stimulation gene-2 (sST2), pentraxin 3 (PTX3), and N-terminal pro-brain natriuretic peptide...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. F. Gareeva, A. F. Khamitova, I. A. Lakman, R. P. Ronzhin, R. Kh. Zulkarneev, M. R. Plotnikova, E. L. Tulbaev, L. J. Motloch, N. Sh. Zagidullin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-12-01
Series:	Российский кардиологический журнал
Subjects:	stemi cardiovascular events cardiovascular death risk stratification sst2 nt-probnp pentraxin-3
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3948
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

Analysis of distant cardiovascular events depending on the biomarker profile in patients with myocardial infarction
by: A. F. Khamitova, et al.
Published: (2019-04-01)

Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology
by: K. D. Dorogoykina, et al.
Published: (2022-05-01)

Conventional (D-dimer) and potential (pentraxin 3 and sST2) biomarkers in long-term prognosis of adverse cardiovascular events in COVID-19 survivors without significant cardiovascular diseases
by: T. V. Kanaeva, et al.
Published: (2025-05-01)

Serum NT-ProBNP/Chloride Ratio Predicts Adverse Cardiovascular Outcomes in Patients with Acute Heart Failure
by: Victor José Leal-Alcántara, et al.
Published: (2025-06-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various implanted devices
by: A. Zh. Gasparyan, et al.
Published: (2020-12-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Diagnostic value of N-terminal pro-B-type natriuretic peptide in hemodialysis patients
by: D. S. Sedov, et al.
Published: (2020-02-01)

Diagnostic value of cardiac marker concentrations in patients with heart failure depending on frailty syndrome
by: V. A. Safronenko, et al.
Published: (2024-10-01)

Serum biomarkers of cardiovascular complications in COVID-19
by: R. M. Gumerov, et al.
Published: (2021-07-01)

New opportunities for biomarkers in cardiovascular risk stratification. Resolution of Advisory board
by: О. M. Drapkina, et al.
Published: (2021-10-01)

TOPICAL DIAGNOSTICS OF SINGLE CORONARY ARTERY OCCLUSION IN ST ELEVATION MYOCARDIAL INFARCTION PATIENTS
by: R. R. Khafizov, et al.
Published: (2017-12-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

Preclinical markers of carotid atherosclerosis and cardiovascular risk assessed by the ESH/ESC scale (2003, 2007, 2009)
by: S. Sh. Urazalina, et al.
Published: (2011-08-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF THE HEART DAMAGE IN METABOLIC SYNDROME
by: R. A. Libis, et al.
Published: (2015-04-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

From ST-segment Myocardial Infarction Networks to Stroke Networks – When Time Is Tissue
by: Buicu Florin, et al.
Published: (2025-07-01)

Assessment of N-terminal pro-brain natriuretic peptide in patients with arrhythmia due to undifferentiated connective tissue disease
by: E. N. Loginova, et al.
Published: (2023-11-01)

N-terminal pro-brain natriuretic peptide as a predictive marker of short-term mortality in sepsis
by: Amit Kumar, et al.
Published: (2025-04-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

Elevation of Cardiac Biomarkers in COVID-19 As a Major Determinant for Mortality: A Systematic Review
by: Tracy Anabella Hermansyah, et al.
Published: (2022-01-01)

Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity
by: O. V. Tsygankova, et al.
Published: (2024-08-01)

Informativeness of various predictors of perioperative cardiovascular complications in non-cardiac surgery
by: D. A. Sokolov, et al.
Published: (2023-05-01)

Renal venous Doppler ultrasound – a new parameter for predicting outcomes in patients with decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2023-07-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

THE LEVEL OF CARDIAC PEPTIDE NT-PROBNP INCREASES DURING PRE-ECLAMPSIA OF PREGNANT WOMEN
by: Н. Русой, et al.
Published: (2025-04-01)

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2019-11-01)

PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS
by: D. G. Shakhin, et al.
Published: (2017-12-01)

Subclinical atherosclerosis diagnostics as a component of a modern strategy for cardiovascular risk stratification
by: N. O. Katamadze, et al.
Published: (2012-04-01)

Prediction of adverse outcomes within 12 months after myocardial infarction in patients over 70 years of age with frailty syndrome
by: O. Yu. Aidumova, et al.
Published: (2023-12-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN
by: E. N. Arkhipova, et al.
Published: (2012-10-01)

Pharmacoepidemiological analysis of therapy for chronic heart failure
by: D. D. Monakhova, et al.
Published: (2023-09-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)